Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Science Translational Medicine
|
January 15, 2016
Inhibition of diacylglycerol kinase α restores restimulation-induced cell death and reduces immunopathology in XLP-1
Elisa Ruffo, Valeria Malacarne, Sasha E Larsen, et al.
The Journal of Experimental Medicine
|
November 7, 2012
Congenital B cell lymphocytosis explained by novel germline CARD11 mutations
Andrew L Snow, Wenming Xiao, Jeffrey R Stinson, et al.
Clinical Immunology (Orlando, Fla.)
|
August 10, 2023
Subcutaneous panniculitis-like T-cell lymphoma in two unrelated individuals with BENTA disease
Bradly M Bauman, Batsukh Dorjbal, Stefania Pittaluga, et al.
Journal of Clinical Immunology
|
January 17, 2024
Management of Atopy with Dupilumab and Omalizumab in CADINS Disease
Natalie M Diaz-Cabrera, Bradly M Bauman, Mildred A Iro, et al.
The Journal of Allergy and Clinical Immunology
|
August 11, 2025
Well-differentiated systemic mastocytosis: genetics, mast cell immunophenotypes, and KIT autophosphorylation
Brandon J Schornack, Jeremy C McMurray, Maria Leondaridis, et al.
Scientific Reports
|
December 28, 2022
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19
Paul W Blair, Joost Brandsma, Josh Chenoweth, et al.
American Journal of Human Genetics
|
November 17, 2020
Multiplexed Functional Assessment of Genetic Variants in CARD11
Iana Meitlis, Eric J Allenspach, Bradly M Bauman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 7, 2021
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers
Siâ Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
Open Forum Infectious Diseases
|
January 20, 2022
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers
Si'Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
The Journal of Infectious Diseases
|
October 21, 2021
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection
Zhongyan Lu, Eric D Laing, Jarina Pena DaMata, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Science Translational Medicine
|
January 15, 2016
Inhibition of diacylglycerol kinase α restores restimulation-induced cell death and reduces immunopathology in XLP-1
Elisa Ruffo, Valeria Malacarne, Sasha E Larsen, et al.
The Journal of Experimental Medicine
|
November 7, 2012
Congenital B cell lymphocytosis explained by novel germline CARD11 mutations
Andrew L Snow, Wenming Xiao, Jeffrey R Stinson, et al.
Clinical Immunology (Orlando, Fla.)
|
August 10, 2023
Subcutaneous panniculitis-like T-cell lymphoma in two unrelated individuals with BENTA disease
Bradly M Bauman, Batsukh Dorjbal, Stefania Pittaluga, et al.
Journal of Clinical Immunology
|
January 17, 2024
Management of Atopy with Dupilumab and Omalizumab in CADINS Disease
Natalie M Diaz-Cabrera, Bradly M Bauman, Mildred A Iro, et al.
The Journal of Allergy and Clinical Immunology
|
August 11, 2025
Well-differentiated systemic mastocytosis: genetics, mast cell immunophenotypes, and KIT autophosphorylation
Brandon J Schornack, Jeremy C McMurray, Maria Leondaridis, et al.
Scientific Reports
|
December 28, 2022
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19
Paul W Blair, Joost Brandsma, Josh Chenoweth, et al.
American Journal of Human Genetics
|
November 17, 2020
Multiplexed Functional Assessment of Genetic Variants in CARD11
Iana Meitlis, Eric J Allenspach, Bradly M Bauman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 7, 2021
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers
Siâ Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
Open Forum Infectious Diseases
|
January 20, 2022
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers
Si'Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
The Journal of Infectious Diseases
|
October 21, 2021
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection
Zhongyan Lu, Eric D Laing, Jarina Pena DaMata, et al.
Page
of 9